Select a Company
11.25 NGN 0 / 0%
As of 11-Apr-2025
Me Cure Industries Plc
Sante Pharmacie et biotechnologie11.25 NGN 0 / 0%
As of 11-Apr-2025
Cours veille
11.25
Volume
5,236
Valeur Transactions
NGN 53,145.40
Deals
4
Actions en Circulation
4,000.00 mln
Capitalisation
NGN 45,000.00 mln
Loading Chart ...
52W RANGE
7.35 - 13.90
1W
--
1M
--
3M
-19.06%
YTD
-19.06%
1Y
+15.74%

Profile
Annonces
Actualité
Rapports
Dividendes
About the company
Me Cure is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine. Products: OTC Medicines, Branded Generics and Dietary Supplements.
Site web
www.mecure.com
info@mecure.com
Site web
www.mecure.com
info@mecure.com
SYMBOL MECURE |
ISIN NGMECURE0006 |
Création 2005 |
Cotation 2023 |
Téléphone - |
FAX - |
Me Cure House, Plot 6, Block H, Apapa Oshodi Expressway, Oshodi, Lagos. Nigeria |
Competitors
Fidson Healthcare Plc | 18.70 | +1.63% |
May & Baker Nigeria Plc | 7.00 | -- |
Neimeth International Pharmaceuticals Plc | 2.88 | -- |
Juli Plc | 10.30 | -- |
Pharma-Deko Plc | 1.83 | -- |
MECURE | Declaration of dividend | 4 mars 2025 |
MECURE | Notice of board meeting | 14 févr. 2025 |
MECURE | Notice of closed period | 6 janv. 2025 |
MECURE | Share dealing | 8 nov. 2024 |
MECURE | Share dealing | 8 nov. 2024 |
MECURE | Notice of board meeting | 23 oct. 2024 |
MECURE | Acquisition of ten Percent Equity Stake | 6 oct. 2024 |
MECURE | Notice of board meeting | 5 août 2024 |
MECURE | AGM resolutions | 8 juil. 2024 |
MECURE | Notice of annual general meeting | 6 juin 2024 |
MECURE | Appointment of independent directors | 16 mai 2024 |
MECURE | Correction of 2023 AFS | 29 avril 2024 |
MECURE | Declaration of dividend | 6 mars 2024 |
MECURE | Rescheduled of board meeting | 27 févr. 2024 |
MECURE | Notice of board meeting | 15 févr. 2024 |
Analyse & Recherche
Rapports Annuels & Financiers
Annual Report | 2023 |
Annual Report | 2022 |
Annual Report | 2021 |
Annual Report | 2020 |
Annual Report | 2019 |
Annual Report | 2018 |
0.15 NGN | 3 juil. 2024 |